ELIQUENT
ELIQUENT Life Sciences
ELIQUENT Life Sciences offers comprehensive regulatory, quality, and safety solutions for pharmaceutical, biotech, and medical device companies. They specialize in navigating complex regulatory landscapes, including QMSR transitions and CMC solutions.
ELIQUENT Life Sciences is a premier global consulting group providing integrated regulatory affairs, pharmacovigilance, quality, and compliance solutions. They support pharmaceutical, biotechnology, medical device, and combination product companies across various therapeutic modalities and global markets. With a team of former regulators and industry leaders, ELIQUENT offers unparalleled expertise in guiding clients through the entire product lifecycle, from early development to post-approval support. Their services are designed to bring clarity to regulatory complexity, ensuring clients gain and maintain market authorization. ELIQUENT is particularly adept at assisting companies with critical transitions, such as the FDA's shift from QSR to QMSR for medical device manufacturers. They provide tailored solutions, expert commentary, and resources to ensure a smooth and successful adaptation to new regulatory frameworks. Their CMC solutions and remediation services further support companies in achieving and maintaining compliance. Their foundation is built on experts with extensive strategic and technical skills, offering objective and reliable guidance. ELIQUENT's global presence and network of experts enable them to solve complex technical challenges on a global scale, making them a trusted partner for life science innovators.
About
**Who they are**
ELIQUENT Life Sciences is a provider of regulatory, quality, and safety solutions for the pharmaceutical, biotech, and medical device industries. They focus on assisting companies in navigating complex regulatory environments.
**Expertise & scope**
* Specializes in the FDA's transition from the Quality System Regulation (QSR) to the new Quality Management System Regulation (QMSR).
* Offers tailored solutions for medical device, in-vitro diagnostic, and combination product manufacturers to adapt to the QMSR framework.
* Provides expertise in areas including regulatory affairs, CMC solutions, quality and compliance, pharmacovigilance, risk management, talent solutions, remediation, and GxP consulting.
* Supports organizations throughout the entire product lifecycle.
**Reputation / proof points**
* The company emphasizes its assembly of regulatory leaders, industry experts, and technical specialists.
ELIQUENT Life Sciences is a provider of regulatory, quality, and safety solutions for the pharmaceutical, biotech, and medical device industries. They focus on assisting companies in navigating complex regulatory environments.
**Expertise & scope**
* Specializes in the FDA's transition from the Quality System Regulation (QSR) to the new Quality Management System Regulation (QMSR).
* Offers tailored solutions for medical device, in-vitro diagnostic, and combination product manufacturers to adapt to the QMSR framework.
* Provides expertise in areas including regulatory affairs, CMC solutions, quality and compliance, pharmacovigilance, risk management, talent solutions, remediation, and GxP consulting.
* Supports organizations throughout the entire product lifecycle.
**Reputation / proof points**
* The company emphasizes its assembly of regulatory leaders, industry experts, and technical specialists.
Additional information
ELIQUENT highlights the upcoming enforcement of the FDA's Quality Management System Regulation (QMSR) on February 2, 2026. They offer resources and insights to help medical device manufacturers prepare for this significant shift. The new QMSR is harmonized with international QMS standards and promotes a data-driven, risk-based approach, impacting quality management processes and regulatory inspection responsibilities. ELIQUENT positions itself as a partner to ensure a smooth adaptation to this evolving regulatory landscape.
Key Highlights
-
Specializes in supporting the FDA's transition from QSR to QMSR for medical device, in-vitro diagnostic, and combination product industries.
Source
“The FDA’s transition from the Quality System Regulation (QSR) to the new Quality Management System Regulation (QMSR) marks a pivotal shift for the medical device, in-vitro diagnostic, and combination product industry.”
-
Offers comprehensive regulatory, quality, and safety solutions.
Source
“ELIQUENT Life Sciences offers comprehensive regulatory, quality, and safety solutions for pharmaceutical, biotech, and medical device companies.”
-
Emphasizes a data-driven, risk-based approach in QMSR, harmonized with international QMS standards.
Source
“The new streamlined regulation is harmonized with internationally recognized QMS standards and emphasizes a data driven risk-based approach”
Certifications & Trust Signals
-
Composed of an assembly of regulatory leaders, industry experts, and technical specialists.
Source
“Our unprecedented assembly of regulatory leaders, industry experts, and technical specialists collaborate seamlessly”
Buyer Snapshot
Best for
- Medical device, in-vitro diagnostic, and combination product manufacturers facing QMSR transition.
How engagement typically works
- Collaborative partnership with regulatory leaders and industry experts.
Typical deliverables
- Tailored QMSR transition solutions.
- Regulatory affairs support.
- CMC solutions.
- Quality and compliance consulting.
Good to know
- Best when organizations need to navigate complex regulatory changes and ensure inspection readiness.
HQ:
United States, US
Languages:
English
Timezones:
EST, PST
Claim status:
Listed
Services & Capabilities
FDA QMSR Transition & Inspection Readiness (ISO 13485 Alignment)
Jurisdictions:
US
Countries:
US
Industries:
Medical Devices, IVD
Onboarding time:
7–21 days
Pricing model:
Custom pricing
Service Types:
QMSR/ISO 13485 Gap Assessment, SOP / Documentation Remediation, CAPA & Nonconformance Remediation
Earliest Start:
flexible
Delivery Mode:
Hybrid
Inspection Experience:
Former FDA investigator on team, Supports mock inspections regularly, ISO 13485 lead auditor capability
Additional fda_qmsr_transition_inspection_readiness Details
Service Types
QMSR/ISO 13485 Gap Assessment, SOP/Documentation Remediation, Training & Competency Programs, Mock FDA Inspection, 483 Response & Remediation Support
Earliest Start
flexible
Delivery Mode
Hybrid
Inspection Experience
Supports mock inspections regularly
